FDA Clearance Tracker · DEN180004
picoAMH ELISA
Last checked: Nov 19, 2026Latest source record: Oct 24, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Oct 24, 2018
De Novo granted
Time to decision
275 days
Received Jan 22, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN180004
- Device name
- picoAMH ELISA
- Applicant
- Ansh Labs, LLC
- Applicant location
- Webster, TX
- Received
- Jan 22, 2018
- Decided
- Oct 24, 2018
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device type
- Menopause Test System (QDH)
- Device class
- Class II
- Regulation
- 21 CFR 862.1093
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN180004
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Ansh Labs, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.